Flavonoids from orostachys japonicus A. berger inhibit the invasion of LnCaP prostate carcinoma cells by inactivating Akt and modulating tight junctions

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18407-18420

  Shin, Dong Yeok ^a   Lee, Won Sup ^b   Jung, Ji Hyun ^b   Hong, Su Hyun ^c   Park, Cheol ^d   Kim, Hye Jung ^b   Kim, Gi Young ^e   Hwang, Hye Jin ^d   Kim, Gon Sup ^f   Jung, Jin Myung ^b   Ryu, Chung Ho ^f   Shin, Sung Chul ^f   Hong, Soon Chan ^b   Choi, Yung Hyun ^c  

^a Dongnam Institute of Radiological and Medical Science   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Dong Eui University   (South Korea)

^d Dong Eui University   (South Korea)

^e Jeju National University   (South Korea)

^f Gyeongsang National University   (South Korea)

Author keywords

Akt; Flavonoids; LnCaP cells; Orostachys japonicus; Tight junctions

Indexed keywords

ANTIMETASTATIC AGENT; CLAUDIN; FLAVONOID; GELATINASE A; GELATINASE B; OROSTACHYS JAPONICUS EXTRACT; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CARCINOMA CELL; CELL MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LILIACEAE; MALE; METASTASIS INHIBITION; NONHUMAN; OROSTACHYS JAPONICUS; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; TUMOR INVASION;

CELL LINE, TUMOR; CELL PROLIFERATION; CRASSULACEAE; FLAVONOIDS; HUMANS; MALE; ONCOGENE PROTEIN V-AKT; PROSTATIC NEOPLASMS; TIGHT JUNCTIONS;

EID: 84883662444     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918407     Document Type: Article

References (28)

1. Schneeberger, E.E.; Lynch, R.D. The tight junction: A multifunctional complex. Am. J. Physiol. Cell Physiol. 2004, 286, C1213-C1228.
2. Soler, A.P.; Miller, R.D.; Laughlin, K.V.; Carp, N.Z.; Klurfeld, D.M.; Mullin, J.M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999, 20, 1425-1431.
3. Tsukita, S.; Furuse, M. Occludin and claudins in tight-junction strands: Leading or supporting players? Trends Cell Biol. 1999, 9, 268-273.
4. Tsukita, S.; Furuse, M. Pores in the wall: Claudins constitute tight junction strands containing aqueous pores. J. Cell Biol. 2000, 149, 13-16.
5. Ruffer, C.; Gerke, V. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur. J. Cell Biol. 2004, 83, 135-144.
6. Mees, S.T.; Mennigen, R.; Spieker, T.; Rijcken, E.; Senninger, N.; Haier, J.; Bruewer, M. Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: Upregulation of claudin-1, claudin-3, claudin-4, and beta-catenin. Int. J. Colorectal. Dis. 2009, 24, 361-368.
7. Morin, P.J. Claudin proteins in human cancer: Promising new targets for diagnosis and therapy. Cancer Res. 2005, 65, 9603-9606.
8. Rangel, L.B.; Agarwal, R.; D'Souza, T.; Pizer, E.S.; Alo, P.L.; Lancaster, W.D.; Gregoire, L.; Schwartz, D.R.; Cho, K.R.; Morin, P.J. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 2003, 9, 2567-2575.
9. Agarwal, R.; D'Souza, T.; Morin, P.J. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005, 65, 7378-7385.
10. Matrisian, L.M. The matrix-degrading metalloproteinases. Bioessays 1992, 14, 455-463.
11. Wang, F.; He, W.; Wang, P.F.; Fan, Q. NF-κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase-9 and epithelial-to-mesenchymal transition. Cell Biol. Int. 2013, 37, 780-788.
12. Zhao, X.L.; Sun, T.; Che, N.; Sun, D.; Zhao, N.; Dong, X.Y.; Gu, Q.; Yao, Z.; Sun, B.C. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J. Cell Mol. Med. 2011, 15, 691-700.
13. Surh, Y.J. Transcription factors in the cellular signaling network as prime targets of chemopreventive phytochemicals. Cancer Res. Treat. 2004, 36, 275-286.
14. Ryu, D.S.; Lee, H.S.; Lee, G.S.; Lee, D.S. Effects of the ethylacetate extract of Orostachys japonicus on induction of apoptosis through the p53-mediated signaling pathway in human gastric cancer cells. Biol. Pharm. Bull. 2012, 35, 660-665.
15. Jung, K.W.; Won, Y.J.; Kong, H.J.; Oh, C.M.; Seo, H.G.; Lee, J.S. Cancer statistics in Korea: Incidence, mortality, survival and prevalence in 2010. Cancer Res. Treat. 2013, 45, 1-14.
16. Jung, K.W.; Won, Y.J.; Kong, H.J.; Oh, C.M.; Seo, H.G.; Lee, J.S. Prediction of cancer incidence and mortality in Korea, 2013. Cancer Res. Treat. 2013, 45, 15-21.
17. Liu, X.W.; Bernardo, M.M.; Fridman, R.; Kim, H.R. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J. Biol. Chem. 2003, 278, 40364-40372.
18. Shin, D.Y.; Lu, J.N.; Kim, G.Y.; Jung, J.M.; Kang, H.S.; Lee, W.S.; Choi, Y.H. Anti-invasive activities of anthocyanins through modulation of tight junctions and suppression of matrix metalloproteinase activities in HCT-116 human colon carcinoma cells. Oncol. Rep. 2011, 25, 567-572.
19. Cereijido, M.; Robbins, E.S.; Dolan, W.J.; Rotunno, C.A.; Sabatini, D.D. Polarized monolayers formed by epithelial cells on a permeable and translucent support. J. Cell. Biol. 1978, 77, 853-880.
20. Davies, B.; Waxman, J.; Wasan, H.; Abel, P.; Williams, G.; Krausz, T.; Neal, D.; Thomas, D.; Hanby, A.; Balkwill, F. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993, 53, 5365-5369.
21. Vihinen, P.; Kahari, V.M. Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. Int. J. Cancer 2002, 99, 157-166.
22. Lu, K.V.; Jong, K.A.; Rajasekaran, A.K.; Cloughesy, T.F.; Mischel, P.S. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab. Invest. 2004, 84, 8-20.
23. Wang, Z.; Juttermann, R.; Soloway, P.D. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J. Biol. Chem. 2000, 275, 26411-26415.
24. Milia-Argeiti, E.; Huet, E.; Labropoulou, V.T.; Mourah, S.; Fenichel, P.; Karamanos, N.K.; Menashi, S.; Theocharis, A.D. Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours. Int. J. Androl. 2012, 35, 835-844.
25. Mashhadiabbas, F.; Mahjour, F.; Mahjour, S.B.; Fereidooni, F.; Hosseini, F.S. The immunohistochemical characterization of MMP-2, MMP-10, TIMP-1, TIMP-2, and podoplanin in oral squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2012, 114, 240-250.
26. Kossakowska, A.E.; Edwards, D.R.; Prusinkiewicz, C.; Zhang, M.C.; Guo, D.; Urbanski, S.J.; Grogan, T.; Marquez, L.A.; Janowska-Wieczorek, A. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood 1999, 94, 2080-2089.
27. Jeong, J.W.; Jin, C.Y.; Park, C.; Han, M.H.; Kim, G.Y.; Moon, S.K.; Kim, C.G.; Jeong, Y.K.; Kim, W.J.; Lee J.D.; et al. Inhibition of migration and invasion of LnCaP human prostate carcinoma cells by cordycepin through inactivation of Akt. Int. J. Oncol. 2012, 40, 1697-1704.
28. low/HER3 dimers on heregulin-beta1-induced MMP-1 and MMP-9 expression in breast cancer cells. Exp. Mol. Med. 2012, 44, 473-482.